Predictive 5-year survivorship model of cystic fibrosis.

712 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Polymicrobial Interactions: Impact on Pathogenesis and Human Disease (2012, methodology): “analyzed data obtained from 5,820 randomly selected patients to develop a multivariate 5-year survivorship model and to partially identify predictors of disease outcomes (122).”
Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. (2003, background): “eters associated with morbidity and mortality in CF.(27) Pulmonary function and nutritional status improved, pulmonary exacerbation rates decreased, and there was some evidence of improved quality of life.”
Diversity and significance of Burkholderia species occupying diverse ecological niches. (2003, background): “The improvement of antimicrobial therapy has contributed significantly to the increased median survival age but chronic pulmonary infection is still the leading cause of death among CF patients (Liou et al., 2001).”
Pathophysiology and management of pulmonary infections in cystic fibrosis. (2003, background): “In addition to acute morbidity, repeated exacerbations may have long-term negative impact on lung function and lifespan (194).”
Development of the New Lung Allocation System in the United States (2006, background): “nized as a major predictor of mortality among CF patients in the CF registry (5).”